Mitochondrial-inflammation crosstalk in major depressive disorder: molecular mechanisms and therapeutic implications.
Preclinical and clinical studies indicate that conventional antidepressants gradually restore mitochondrial function while suppressing oxidative and inflammatory stress, whereas rapid-acting agents such as ketamine induce acute metabolic reprogramming and mitophagy, enabling swift functional recovery.